Drug intelligence / Profile preview

Renshen Yangrong Wan

Development stage
Unknown
Lead developer
Henan Jindan Lactic Acid Technology
Administration
Oral
01

Overview

Renshen Yangrong Wan is a traditional Chinese medicine (TCM) formula produced by Liaoning Jindan Pharmaceutical. It is primarily indicated for the replenishment of Qi and the nourishment of blood, specifically targeting syndromes characterized by deficiencies in both. Clinical applications include the treatment of physical exhaustion, palpitations, shortness of breath, insomnia, cold extremities, and poor appetite. The formula is a complex mixture of herbal ingredients, typically including *Panax ginseng* (Renshen), *Atractylodes macrocephala* (Baizhu), *Poria cocos* (Fuling), *Glycyrrhiza uralensis* (Gancao), *Angelica sinensis* (Danggui), *Rehmannia glutinosa* (Shudihuang), *Paeonia lactiflora* (Baishao), *Cinnamomum cassia* (Rougui), *Citrus reticulata* (Chenpi), *Polygala tenuifolia* (Yuanzhi), and *Schisandra chinensis* (Wuweizi). It is an approved and marketed product in China, often used for recovery after illness or for chronic fatigue states.

Brand names
Renshen Yangrong Wan
Other names
Ginseng Nutritive PillsRen Shen Yang Rong Wan
02

Targets

KCNH2 (Voltage-gated potassium channel subfamily H member 2)NOS3 (eNOS)GAA (Lysosomal acid alpha-glucosidase)MMP9 (Matrix metalloproteinase-9)SLC16A1 (Mitochondrial Pyruvate Carrier)SIRT1 (NAD-dependent protein deacetylase sirtuin-1)

Beyond the preview

Go deeper on Renshen Yangrong Wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Renshen Yangrong Wan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call